Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Linda Watkins to Humans

This is a "connection" page, showing publications Linda Watkins has written about Humans.

 
Connection Strength
 
 
 
0.532
 
  1. Grace PM, Watkins LR. Reordering neuroimmune signaling to prevent and resolve chronic pain. Pain. 2025 Nov 01; 166(11S):S19-S22.
    View in: PubMed
    Score: 0.023
  2. Green-Fulgham SM, Ball JB, Kwilasz AJ, Harland ME, Frank MG, Dragavon JM, Grace PM, Watkins LR. Interleukin-1beta and inflammasome expression in spinal cord following chronic constriction injury in male and female rats. Brain Behav Immun. 2024 01; 115:157-168.
    View in: PubMed
    Score: 0.020
  3. Clements MA, Kwilasz AJ, Litwiler ST, Sents Z, Woodall BJ, Hayashida K, Watkins LR. Intrathecal non-viral interleukin-10 gene therapy ameliorates neuropathic pain as measured by both classical static allodynia and a novel supra-spinally mediated pain assay, the Two-Arm Rodent Somatosensory (TARS) task. Brain Behav Immun. 2023 07; 111:177-185.
    View in: PubMed
    Score: 0.019
  4. Ball JB, Green-Fulgham SM, Watkins LR. Mechanisms of microglia-mediated synapse turnover and synaptogenesis. Prog Neurobiol. 2022 11; 218:102336.
    View in: PubMed
    Score: 0.019
  5. Harris KM, Clements MA, Kwilasz AJ, Watkins LR. T cell transgressions: Tales of T cell form and function in diverse disease states. Int Rev Immunol. 2022; 41(5):475-516.
    View in: PubMed
    Score: 0.017
  6. Grace PM, Gaudet AD, Staikopoulos V, Maier SF, Hutchinson MR, Salvemini D, Watkins LR. Nitroxidative Signaling Mechanisms in Pathological Pain. Trends Neurosci. 2016 12; 39(12):862-879.
    View in: PubMed
    Score: 0.012
  7. Grace PM, Maier SF, Watkins LR. Opioid-induced central immune signaling: implications for opioid analgesia. Headache. 2015 Apr; 55(4):475-89.
    View in: PubMed
    Score: 0.011
  8. Bachtell R, Hutchinson MR, Wang X, Rice KC, Maier SF, Watkins LR. Targeting the Toll of Drug Abuse: The Translational Potential of Toll-Like Receptor 4. CNS Neurol Disord Drug Targets. 2015; 14(6):692-9.
    View in: PubMed
    Score: 0.011
  9. Kwilasz AJ, Grace PM, Serbedzija P, Maier SF, Watkins LR. The therapeutic potential of interleukin-10 in neuroimmune diseases. Neuropharmacology. 2015 Sep; 96(Pt A):55-69.
    View in: PubMed
    Score: 0.011
  10. Lewis SS, Hutchinson MR, Frick MM, Zhang Y, Maier SF, Sammakia T, Rice KC, Watkins LR. Select steroid hormone glucuronide metabolites can cause toll-like receptor 4 activation and enhanced pain. Brain Behav Immun. 2015 Feb; 44:128-36.
    View in: PubMed
    Score: 0.011
  11. Watkins LR, Wang X, Mustafa S, Hutchinson MR. In vivo veritas: (+)-Naltrexone's actions define translational importance: A letter in response to Skolnick et al. 'Translational potential of naloxone and naltrexone as TLR4 antagonists'. Trends Pharmacol Sci. 2014 Sep; 35(9):432-3.
    View in: PubMed
    Score: 0.011
  12. Watkins LR, Hutchinson MR. A concern on comparing 'apples' and 'oranges' when differences between microglia used in human and rodent studies go far, far beyond simply species: comment on Smith and Dragunow. Trends Neurosci. 2014 Apr; 37(4):189-90.
    View in: PubMed
    Score: 0.010
  13. Grace PM, Hutchinson MR, Maier SF, Watkins LR. Pathological pain and the neuroimmune interface. Nat Rev Immunol. 2014 Apr; 14(4):217-31.
    View in: PubMed
    Score: 0.010
  14. Hutchinson MR, Watkins LR. Why is neuroimmunopharmacology crucial for the future of addiction research? Neuropharmacology. 2014 Jan; 76 Pt B:218-27.
    View in: PubMed
    Score: 0.010
  15. Lewis SS, Hutchinson MR, Zhang Y, Hund DK, Maier SF, Rice KC, Watkins LR. Glucuronic acid and the ethanol metabolite ethyl-glucuronide cause toll-like receptor 4 activation and enhanced pain. Brain Behav Immun. 2013 May; 30:24-32.
    View in: PubMed
    Score: 0.010
  16. Lewis SS, Loram LC, Hutchinson MR, Li CM, Zhang Y, Maier SF, Huang Y, Rice KC, Watkins LR. (+)-naloxone, an opioid-inactive toll-like receptor 4 signaling inhibitor, reverses multiple models of chronic neuropathic pain in rats. J Pain. 2012 May; 13(5):498-506.
    View in: PubMed
    Score: 0.009
  17. Watkins LR, Hutchinson MR, Johnson KW. Commentary on Landry et al.: "Propentofylline, a CNS glial modulator, does not decrease pain in post-herpetic neuralgia patients: in vitro evidence for differential responses in human and rodent microglia and macrophages". Exp Neurol. 2012 Apr; 234(2):351-3.
    View in: PubMed
    Score: 0.009
  18. Johnston IN, Maier SF, Rudy JW, Watkins LR. Post-conditioning experience with acute or chronic inflammatory pain reduces contextual fear conditioning in the rat. Behav Brain Res. 2012 Jan 15; 226(2):361-8.
    View in: PubMed
    Score: 0.009
  19. Hutchinson MR, Shavit Y, Grace PM, Rice KC, Maier SF, Watkins LR. Exploring the neuroimmunopharmacology of opioids: an integrative review of mechanisms of central immune signaling and their implications for opioid analgesia. Pharmacol Rev. 2011 Sep; 63(3):772-810.
    View in: PubMed
    Score: 0.009
  20. Maier SF, Watkins LR. Role of the medial prefrontal cortex in coping and resilience. Brain Res. 2010 Oct 08; 1355:52-60.
    View in: PubMed
    Score: 0.008
  21. Hutchinson MR, Loram LC, Zhang Y, Shridhar M, Rezvani N, Berkelhammer D, Phipps S, Foster PS, Landgraf K, Falke JJ, Rice KC, Maier SF, Yin H, Watkins LR. Evidence that tricyclic small molecules may possess toll-like receptor and myeloid differentiation protein 2 activity. Neuroscience. 2010 Jun 30; 168(2):551-63.
    View in: PubMed
    Score: 0.008
  22. Watkins LR, Hutchinson MR, Rice KC, Maier SF. The "toll" of opioid-induced glial activation: improving the clinical efficacy of opioids by targeting glia. Trends Pharmacol Sci. 2009 Nov; 30(11):581-91.
    View in: PubMed
    Score: 0.008
  23. Bartley J, Watkins LR. Comment on: excessive opioid use and the development of chronic migraine. Pain. 2009 Sep; 145(1-2):262-3.
    View in: PubMed
    Score: 0.007
  24. Milligan ED, Watkins LR. Pathological and protective roles of glia in chronic pain. Nat Rev Neurosci. 2009 Jan; 10(1):23-36.
    View in: PubMed
    Score: 0.007
  25. Hutchinson MR, Zhang Y, Brown K, Coats BD, Shridhar M, Sholar PW, Patel SJ, Crysdale NY, Harrison JA, Maier SF, Rice KC, Watkins LR. Non-stereoselective reversal of neuropathic pain by naloxone and naltrexone: involvement of toll-like receptor 4 (TLR4). Eur J Neurosci. 2008 Jul; 28(1):20-9.
    View in: PubMed
    Score: 0.007
  26. Hutchinson MR, Bland ST, Johnson KW, Rice KC, Maier SF, Watkins LR. Opioid-induced glial activation: mechanisms of activation and implications for opioid analgesia, dependence, and reward. ScientificWorldJournal. 2007 Nov 02; 7:98-111.
    View in: PubMed
    Score: 0.007
  27. Watkins LR, Hutchinson MR, Milligan ED, Maier SF. "Listening" and "talking" to neurons: implications of immune activation for pain control and increasing the efficacy of opioids. Brain Res Rev. 2007 Nov; 56(1):148-69.
    View in: PubMed
    Score: 0.007
  28. Watkins LR, Hutchinson MR, Ledeboer A, Wieseler-Frank J, Milligan ED, Maier SF. Norman Cousins Lecture. Glia as the "bad guys": implications for improving clinical pain control and the clinical utility of opioids. Brain Behav Immun. 2007 Feb; 21(2):131-46.
    View in: PubMed
    Score: 0.006
  29. Milligan ED, Sloane EM, Langer SJ, Hughes TS, Jekich BM, Frank MG, Mahoney JH, Levkoff LH, Maier SF, Cruz PE, Flotte TR, Johnson KW, Mahoney MM, Chavez RA, Leinwand LA, Watkins LR. Repeated intrathecal injections of plasmid DNA encoding interleukin-10 produce prolonged reversal of neuropathic pain. Pain. 2006 Dec 15; 126(1-3):294-308.
    View in: PubMed
    Score: 0.006
  30. Banks WA, Watkins LR. Mediation of chronic pain: not by neurons alone. Pain. 2006 Sep; 124(1-2):1-2.
    View in: PubMed
    Score: 0.006
  31. Hodges PW, Fiore NT, Watkins LR, Klyne DM, Coppieters MW, Grace PM. Pain and the immune system. Musculoskelet Sci Pract. 2026 Apr; 82:103484.
    View in: PubMed
    Score: 0.006
  32. Maier SF, Amat J, Baratta MV, Paul E, Watkins LR. Behavioral control, the medial prefrontal cortex, and resilience. Dialogues Clin Neurosci. 2006; 8(4):397-406.
    View in: PubMed
    Score: 0.006
  33. Watkins LR, Hutchinson MR, Johnston IN, Maier SF. Glia: novel counter-regulators of opioid analgesia. Trends Neurosci. 2005 Dec; 28(12):661-9.
    View in: PubMed
    Score: 0.006
  34. Milligan ED, Langer SJ, Sloane EM, He L, Wieseler-Frank J, O'Connor K, Martin D, Forsayeth JR, Maier SF, Johnson K, Chavez RA, Leinwand LA, Watkins LR. Controlling pathological pain by adenovirally driven spinal production of the anti-inflammatory cytokine, interleukin-10. Eur J Neurosci. 2005 Apr; 21(8):2136-48.
    View in: PubMed
    Score: 0.006
  35. Wieseler-Frank J, Maier SF, Watkins LR. Immune-to-brain communication dynamically modulates pain: physiological and pathological consequences. Brain Behav Immun. 2005 Mar; 19(2):104-11.
    View in: PubMed
    Score: 0.006
  36. Milligan ED, Sloane EM, Langer SJ, Cruz PE, Chacur M, Spataro L, Wieseler-Frank J, Hammack SE, Maier SF, Flotte TR, Forsayeth JR, Leinwand LA, Chavez R, Watkins LR. Controlling neuropathic pain by adeno-associated virus driven production of the anti-inflammatory cytokine, interleukin-10. Mol Pain. 2005 Feb 25; 1:9.
    View in: PubMed
    Score: 0.006
  37. Watkins LR, Maier SF. Immune regulation of central nervous system functions: from sickness responses to pathological pain. J Intern Med. 2005 Feb; 257(2):139-55.
    View in: PubMed
    Score: 0.006
  38. Maier SF, Watkins LR. Stressor controllability and learned helplessness: the roles of the dorsal raphe nucleus, serotonin, and corticotropin-releasing factor. Neurosci Biobehav Rev. 2005; 29(4-5):829-41.
    View in: PubMed
    Score: 0.005
  39. Wieseler-Frank J, Maier SF, Watkins LR. Central proinflammatory cytokines and pain enhancement. Neurosignals. 2005; 14(4):166-74.
    View in: PubMed
    Score: 0.005
  40. Wieseler-Frank J, Maier SF, Watkins LR. Glial activation and pathological pain. Neurochem Int. 2004 Jul-Aug; 45(2-3):389-95.
    View in: PubMed
    Score: 0.005
  41. Zhang X, Xu Q, Liu Z, Ball JB, Black B, Ganguly S, Harland ME, Blackman S, Bryant S, Anseth K, Watkins L, Liu X. Chandipura viral glycoprotein (CNV-G) promotes Gectosome generation and enables delivery of intracellular therapeutics. Mol Ther. 2024 Jul 03; 32(7):2264-2285.
    View in: PubMed
    Score: 0.005
  42. Li H, Watkins LR, Wang X. Microglia in neuroimmunopharmacology and drug addiction. Mol Psychiatry. 2024 Jun; 29(6):1912-1924.
    View in: PubMed
    Score: 0.005
  43. Watkins LR, Maier SF. Glia: a novel drug discovery target for clinical pain. Nat Rev Drug Discov. 2003 Dec; 2(12):973-85.
    View in: PubMed
    Score: 0.005
  44. Green-Fulgham SM, Lacagnina MJ, Willcox KF, Li J, Harland ME, Ciena AP, Rocha IRC, Ball JB, Dreher RA, Zuberi YA, Dragavon JM, Chacur M, Maier SF, Watkins LR, Grace PM. Voluntary wheel running prevents formation of membrane attack complexes and myelin degradation after peripheral nerve injury. Brain Behav Immun. 2024 01; 115:419-431.
    View in: PubMed
    Score: 0.005
  45. Maier SF, Watkins LR. Immune-to-central nervous system communication and its role in modulating pain and cognition: Implications for cancer and cancer treatment. Brain Behav Immun. 2003 Feb; 17 Suppl 1:S125-31.
    View in: PubMed
    Score: 0.005
  46. Watkins LR, Milligan ED, Maier SF. Glial proinflammatory cytokines mediate exaggerated pain states: implications for clinical pain. Adv Exp Med Biol. 2003; 521:1-21.
    View in: PubMed
    Score: 0.005
  47. Watkins LR, Maier SF. Beyond neurons: evidence that immune and glial cells contribute to pathological pain states. Physiol Rev. 2002 Oct; 82(4):981-1011.
    View in: PubMed
    Score: 0.005
  48. Watkins LR, Milligan ED, Maier SF. Spinal cord glia: new players in pain. Pain. 2001 Sep; 93(3):201-205.
    View in: PubMed
    Score: 0.004
  49. Watkins LR, Milligan ED, Maier SF. Glial activation: a driving force for pathological pain. Trends Neurosci. 2001 Aug; 24(8):450-5.
    View in: PubMed
    Score: 0.004
  50. Pugh CR, Johnson JD, Martin D, Rudy JW, Maier SF, Watkins LR. Human immunodeficiency virus-1 coat protein gp120 impairs contextual fear conditioning: a potential role in AIDS related learning and memory impairments. Brain Res. 2000 Apr 07; 861(1):8-15.
    View in: PubMed
    Score: 0.004
  51. Watkins LR, Maier SF. The pain of being sick: implications of immune-to-brain communication for understanding pain. Annu Rev Psychol. 2000; 51:29-57.
    View in: PubMed
    Score: 0.004
  52. Watkins LR, Maier SF. Implications of immune-to-brain communication for sickness and pain. Proc Natl Acad Sci U S A. 1999 Jul 06; 96(14):7710-3.
    View in: PubMed
    Score: 0.004
  53. Frank MG, Fonken LK, Watkins LR, Maier SF. Microglia: Neuroimmune-sensors of stress. Semin Cell Dev Biol. 2019 10; 94:176-185.
    View in: PubMed
    Score: 0.004
  54. Watkins LR, Nguyen KT, Lee JE, Maier SF. Dynamic regulation of proinflammatory cytokines. Adv Exp Med Biol. 1999; 461:153-78.
    View in: PubMed
    Score: 0.004
  55. Maier SF, Nguyen KT, Deak T, Milligan ED, Watkins LR. Stress, learned helplessness, and brain interleukin-1 beta. Adv Exp Med Biol. 1999; 461:235-49.
    View in: PubMed
    Score: 0.004
  56. Watkins LR, Hansen MK, Nguyen KT, Lee JE, Maier SF. Dynamic regulation of the proinflammatory cytokine, interleukin-1beta: molecular biology for non-molecular biologists. Life Sci. 1999; 65(5):449-81.
    View in: PubMed
    Score: 0.004
  57. Frank MG, Fonken LK, Watkins LR, Maier SF, Lowry CA. Could Probiotics Be Used to Mitigate Neuroinflammation? ACS Chem Neurosci. 2019 01 16; 10(1):13-15.
    View in: PubMed
    Score: 0.004
  58. Maier SF, Goehler LE, Fleshner M, Watkins LR. The role of the vagus nerve in cytokine-to-brain communication. Ann N Y Acad Sci. 1998 May 01; 840:289-300.
    View in: PubMed
    Score: 0.003
  59. Maier SF, Watkins LR. Cytokines for psychologists: implications of bidirectional immune-to-brain communication for understanding behavior, mood, and cognition. Psychol Rev. 1998 Jan; 105(1):83-107.
    View in: PubMed
    Score: 0.003
  60. Lacagnina MJ, Watkins LR, Grace PM. Toll-like receptors and their role in persistent pain. Pharmacol Ther. 2018 04; 184:145-158.
    View in: PubMed
    Score: 0.003
  61. Gaudet AD, Fonken LK, Watkins LR, Nelson RJ, Popovich PG. MicroRNAs: Roles in Regulating Neuroinflammation. Neuroscientist. 2018 06; 24(3):221-245.
    View in: PubMed
    Score: 0.003
  62. Das N, Dewan V, Grace PM, Gunn RJ, Tamura R, Tzarum N, Watkins LR, Wilson IA, Yin H. HMGB1 Activates Proinflammatory Signaling via TLR5 Leading to Allodynia. Cell Rep. 2016 10 18; 17(4):1128-1140.
    View in: PubMed
    Score: 0.003
  63. Watkins LR, Maier SF, Goehler LE. Immune activation: the role of pro-inflammatory cytokines in inflammation, illness responses and pathological pain states. Pain. 1995 Dec; 63(3):289-302.
    View in: PubMed
    Score: 0.003
  64. Watkins LR, Goehler LE, Relton J, Brewer MT, Maier SF. Mechanisms of tumor necrosis factor-alpha (TNF-alpha) hyperalgesia. Brain Res. 1995 Sep 18; 692(1-2):244-50.
    View in: PubMed
    Score: 0.003
  65. Frank MG, Watkins LR, Maier SF. The permissive role of glucocorticoids in neuroinflammatory priming: mechanisms and insights. Curr Opin Endocrinol Diabetes Obes. 2015 Aug; 22(4):300-5.
    View in: PubMed
    Score: 0.003
  66. Selfridge BR, Wang X, Zhang Y, Yin H, Grace PM, Watkins LR, Jacobson AE, Rice KC. Structure-Activity Relationships of (+)-Naltrexone-Inspired Toll-like Receptor 4 (TLR4) Antagonists. J Med Chem. 2015 Jun 25; 58(12):5038-52.
    View in: PubMed
    Score: 0.003
  67. Barrientos RM, Kitt MM, Watkins LR, Maier SF. Neuroinflammation in the normal aging hippocampus. Neuroscience. 2015 Nov 19; 309:84-99.
    View in: PubMed
    Score: 0.003
  68. Watkins LR, Maier SF, Goehler LE. Cytokine-to-brain communication: a review & analysis of alternative mechanisms. Life Sci. 1995; 57(11):1011-26.
    View in: PubMed
    Score: 0.003
  69. Jacobsen JH, Watkins LR, Hutchinson MR. Discovery of a novel site of opioid action at the innate immune pattern-recognition receptor TLR4 and its role in addiction. Int Rev Neurobiol. 2014; 118:129-63.
    View in: PubMed
    Score: 0.003
  70. Wang X, Grace PM, Pham MN, Cheng K, Strand KA, Smith C, Li J, Watkins LR, Yin H. Rifampin inhibits Toll-like receptor 4 signaling by targeting myeloid differentiation protein 2 and attenuates neuropathic pain. FASEB J. 2013 Jul; 27(7):2713-22.
    View in: PubMed
    Score: 0.002
  71. Bastos LF, Godin AM, Zhang Y, Jarussophon S, Ferreira BC, Machado RR, Maier SF, Konishi Y, de Freitas RP, Fiebich BL, Watkins LR, Coelho MM, Moraes MF. A minocycline derivative reduces nerve injury-induced allodynia, LPS-induced prostaglandin E2 microglial production and signaling via toll-like receptors 2 and 4. Neurosci Lett. 2013 May 24; 543:157-62.
    View in: PubMed
    Score: 0.002
  72. Frank MG, Watkins LR, Maier SF. Stress-induced glucocorticoids as a neuroendocrine alarm signal of danger. Brain Behav Immun. 2013 Oct; 33:1-6.
    View in: PubMed
    Score: 0.002
  73. Wang X, Fiorini Z, Smith C, Zhang Y, Li J, Watkins LR, Yin H. Repositioning antimicrobial agent pentamidine as a disruptor of the lateral interactions of transmembrane domain 5 of EBV latent membrane protein 1. PLoS One. 2012; 7(10):e47703.
    View in: PubMed
    Score: 0.002
  74. Barrientos RM, Hein AM, Frank MG, Watkins LR, Maier SF. Intracisternal interleukin-1 receptor antagonist prevents postoperative cognitive decline and neuroinflammatory response in aged rats. J Neurosci. 2012 Oct 17; 32(42):14641-8.
    View in: PubMed
    Score: 0.002
  75. Douglass DK, Carstens E, Watkins LR. Spatial summation in human thermal pain perception: comparison within and between dermatomes. Pain. 1992 Aug; 50(2):197-202.
    View in: PubMed
    Score: 0.002
  76. Hughes JP, Chessell I, Malamut R, Perkins M, Backonja M, Baron R, Farrar JT, Field MJ, Gereau RW, Gilron I, McMahon SB, Porreca F, Rappaport BA, Rice F, Richman LK, Segerdahl M, Seminowicz DA, Watkins LR, Waxman SG, Wiech K, Woolf C. Understanding chronic inflammatory and neuropathic pain. Ann N Y Acad Sci. 2012 May; 1255:30-44.
    View in: PubMed
    Score: 0.002
  77. Wang X, Loram LC, Ramos K, de Jesus AJ, Thomas J, Cheng K, Reddy A, Somogyi AA, Hutchinson MR, Watkins LR, Yin H. Morphine activates neuroinflammation in a manner parallel to endotoxin. Proc Natl Acad Sci U S A. 2012 Apr 17; 109(16):6325-30.
    View in: PubMed
    Score: 0.002
  78. Barrientos RM, Frank MG, Watkins LR, Maier SF. Aging-related changes in neuroimmune-endocrine function: implications for hippocampal-dependent cognition. Horm Behav. 2012 Aug; 62(3):219-27.
    View in: PubMed
    Score: 0.002
  79. Bastos LF, de Oliveira AC, Watkins LR, Moraes MF, Coelho MM. Tetracyclines and pain. Naunyn Schmiedebergs Arch Pharmacol. 2012 Mar; 385(3):225-41.
    View in: PubMed
    Score: 0.002
  80. Nicotra L, Loram LC, Watkins LR, Hutchinson MR. Toll-like receptors in chronic pain. Exp Neurol. 2012 Apr; 234(2):316-29.
    View in: PubMed
    Score: 0.002
  81. Liu L, Ghosh N, Slivka PF, Fiorini Z, Hutchinson MR, Watkins LR, Yin H. An MD2 hot-spot-mimicking peptide that suppresses TLR4-mediated inflammatory response in vitro and in vivo. Chembiochem. 2011 Aug 16; 12(12):1827-31.
    View in: PubMed
    Score: 0.002
  82. Campbell IG, Carstens E, Watkins LR. Comparison of human pain sensation and flexion withdrawal evoked by noxious radiant heat. Pain. 1991 Jun; 45(3):259-268.
    View in: PubMed
    Score: 0.002
  83. Joce C, Stahl JA, Shridhar M, Hutchinson MR, Watkins LR, Fedichev PO, Yin H. Application of a novel in silico high-throughput screen to identify selective inhibitors for protein-protein interactions. Bioorg Med Chem Lett. 2010 Sep 15; 20(18):5411-3.
    View in: PubMed
    Score: 0.002
  84. Soderquist RG, Milligan ED, Harrison JA, Chavez RA, Johnson KW, Watkins LR, Mahoney MJ. PEGylation of interleukin-10 for the mitigation of enhanced pain states. J Biomed Mater Res A. 2010 Jun 01; 93(3):1169-79.
    View in: PubMed
    Score: 0.002
  85. Buchanan MM, Hutchinson M, Watkins LR, Yin H. Toll-like receptor 4 in CNS pathologies. J Neurochem. 2010 Jul; 114(1):13-27.
    View in: PubMed
    Score: 0.002
  86. Hughes TS, Langer SJ, Virtanen SI, Chavez RA, Watkins LR, Milligan ED, Leinwand LA. Immunogenicity of intrathecal plasmid gene delivery: cytokine release and effects on transgene expression. J Gene Med. 2009 Sep; 11(9):782-90.
    View in: PubMed
    Score: 0.002
  87. Hughes TS, Langer SJ, Johnson KW, Chavez RA, Watkins LR, Milligan ED, Leinwand LA. Intrathecal injection of naked plasmid DNA provides long-term expression of secreted proteins. Mol Ther. 2009 Jan; 17(1):88-94.
    View in: PubMed
    Score: 0.002
  88. Ledeboer A, Hutchinson MR, Watkins LR, Johnson KW. Ibudilast (AV-411). A new class therapeutic candidate for neuropathic pain and opioid withdrawal syndromes. Expert Opin Investig Drugs. 2007 Jul; 16(7):935-50.
    View in: PubMed
    Score: 0.002
  89. Dworkin RH, Backonja M, Rowbotham MC, Allen RR, Argoff CR, Bennett GJ, Bushnell MC, Farrar JT, Galer BS, Haythornthwaite JA, Hewitt DJ, Loeser JD, Max MB, Saltarelli M, Schmader KE, Stein C, Thompson D, Turk DC, Wallace MS, Watkins LR, Weinstein SM. Advances in neuropathic pain: diagnosis, mechanisms, and treatment recommendations. Arch Neurol. 2003 Nov; 60(11):1524-34.
    View in: PubMed
    Score: 0.001
  90. Barrientos RM, Higgins EA, Sprunger DB, Watkins LR, Rudy JW, Maier SF. Memory for context is impaired by a post context exposure injection of interleukin-1 beta into dorsal hippocampus. Behav Brain Res. 2002 Aug 21; 134(1-2):291-8.
    View in: PubMed
    Score: 0.001
  91. Mirowski M, Mower MM, Reid PR, Watkins L. Implantable automatic defibrillators: their potential in prevention of sudden coronary death. Ann N Y Acad Sci. 1982; 382:371-80.
    View in: PubMed
    Score: 0.001
  92. Hansen MK, O'Connor KA, Goehler LE, Watkins LR, Maier SF. The contribution of the vagus nerve in interleukin-1beta-induced fever is dependent on dose. Am J Physiol Regul Integr Comp Physiol. 2001 Apr; 280(4):R929-34.
    View in: PubMed
    Score: 0.001
  93. Rachal Pugh C, Fleshner M, Watkins LR, Maier SF, Rudy JW. The immune system and memory consolidation: a role for the cytokine IL-1beta. Neurosci Biobehav Rev. 2001 Jan; 25(1):29-41.
    View in: PubMed
    Score: 0.001
  94. Maier SF, Watkins LR, Fleshner M. Psychoneuroimmunology. The interface between behavior, brain, and immunity. Am Psychol. 1994 Dec; 49(12):1004-17.
    View in: PubMed
    Score: 0.001
  95. Mirowski M, Reid PR, Mower MM, Watkins L, Platia EV, Griffith LS, Juanteguy JM. Clinical experience with the implantable cardioverter-defibrillator. Ann N Y Acad Sci. 1984; 427:297-306.
    View in: PubMed
    Score: 0.000
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)